Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.75 USD | -1.38% | -10.52% | +164.95% |
05-10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
05-09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.95% | 2.23B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.83% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Wedbush Raises Vera Therapeutics' Price Target to $21 From $16, Keeps Neutral Rating